CRDL
Cardiol Therapeutics Inc.Healthcare·Drug Manufacturers - Specialty & Generic
$1.22
$136M market cap
Revenue
$0.0M
Free Cash Flow
$-12.8M
Rev Growth
+0.0%
FCF Margin
0.0%
P/FCF
--
EV/FCF
--
Fwd EV/EBITDA
--
Fair Value
--
Upside
--
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx as a cardioprotective therapy to reduce cardiovascular and respiratory events in patients hospitalized with COVID-19,
2-Year Price History
$1.32-45.2%
Quarterly Financials & Projections
Quarterly Waterfall (CAD M)
| Period | Rev | EBITDA | OpIn | NI | OCF | FCF | CapEx | Cash | Debt | Shares | ROIC | IntCov | EV/EBITDA | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Act | 2026-Q1 | 0.0 | -9.7 | -9.7 | -10.9 | -7.5 | -7.6 | -0.1 | 27.7 | 0.1 | 109.0 | -318.4% | -- | -- |
| Act | 2025-Q4 | 0.0 | -8.0 | -8.0 | -7.2 | -5.2 | -5.2 | -0.0 | 21.4 | 0.1 | 100.3 | -541.3% | -- | -- |
Valuation & Metrics
Market Stats
Price$1.22
Market Cap$136M
Enterprise Value$161M
P/S Ratio0.0x
P/FCF--
EV/FCF--
FCF Margin (TTM)0.0%
FCF Yield-6.8%
Dividend Yield (TTM)--
Annual Dilution0.0%
CurrencyUSD
TTM Financial Snapshot
Revenue$0.0M
Net Income$-18.1M
Free Cash Flow$-12.8M
Revenue Growth (YoY)+0.0%
EBITDA Margin0.0%
Net Margin0.0%
FCF Margin0.0%
CapEx % of Revenue0.0%
SBC % of Revenue0.0%
ROIC-429.9%
WC Change % Rev0.0%
Interest Coverage--
Forward Outlook & Risk
Short Interest
Short % of Float--
Short Shares2.0M
Days to Cover2.3
Change (vs Prior)-0.9%
Need at least 2 settlement dates for chart
Employees
Headcount18
Revenue / Employee$0
Gross Profit / Employee$-2,929
Cash Runway
26.0months
WATCH
Institutional Ownership
Headline & net flow
NEUTRAL
Net flow · —still filing
No float data — flow unavailable.
Ownership composition
Active
25.0%(+20.1% YoY)
42 filers
hedge / family / endowment
Retail funds
—
Fidelity, Schwab, 401(k)
Passive
0.0%(+0.0% YoY)
1 filers
Vanguard, iShares, SPDR
Market makers
0.2%(+0.2% YoY)
3 filers
Citadel, Susquehanna
Insiders
—
Form 4 — latest per insider
ActiveRetail fundsPassiveMarket makersRetail direct
Top holders
| Fund | $ value | Cost basis | Δ QoQ | Δ YoY | α life | Fund AUM |
|---|---|---|---|---|---|---|
| MMCAP International Inc. SPC | $20.7M | $1.35 | +$20.4M | +$19.7M | -3.5% | $1.16B |
| Tejara Capital Ltd | $6.9M | $1.09 | +$0 | +$2.6M | -1.8% | $303M |
| Ikarian Capital, LLC | $3.7M | $1.35 | +$3.7M | +$3.7M | -8.9% | $698M |
| CITADEL ADVISORS LLC | $1.1M | $1.23 | +$481K | +$1.1M | -0.4% | $138.22B |
| BOOTHBAY FUND MANAGEMENT, LLC | $1.1M | $1.35 | +$1.1M | +$1.1M | -0.4% | $4.25B |
| TWO SIGMA INVESTMENTS, LP | $721K | $1.10 | +$172K | +$721K | -0.9% | $117.03B |
| INTEGRITY ALLIANCE, LLC. | $630K | $0.98 | +$41K | +$630K | +1.1% | $2.62B |
| GOLDMAN SACHS GROUP INC | $449K | $1.06 | +$5K | +$396K | -0.2% | $760.93B |
| MORGAN STANLEY | $338K | $1.23 | −$127K | +$258K | -0.3% | $1.65T |
| RENAISSANCE TECHNOLOGIES LLC | $310K | $1.35 | +$297K | +$310K | +1.2% | $63.91B |
| JANE STREET GROUP, LLCMM | $172K | $1.11 | +$118K | +$172K | -0.1% | $92.10B |
| Summit Financial, LLC | $140K | $1.07 | +$0 | +$140K | +0.0% | $7.75B |
| 1832 Asset Management L.P. | $135K | $0.95 | +$0 | +$135K | -0.2% | $75.48B |
| Knoll Capital Management, LLC | $135K | $2.02 | +$0 | +$0 | -5.5% | $180M |
| We Are One Seven, LLC | $135K | $0.93 | +$0 | +$0 | +0.3% | $4.91B |
| SUSQUEHANNA INTERNATIONAL GROUP, LLPMM | $95K | $0.95 | −$180K | +$95K | -0.6% | $77.14B |
| GEODE CAPITAL MANAGEMENT, LLCPassive | $71K | $1.32 | +$0 | +$0 | +2.3% | $1.61T |
| Quadrature Capital Ltd | $65K | $1.35 | +$65K | +$65K | +1.3% | $8.40B |
| JPMORGAN CHASE & CO | $59K | $1.38 | +$62K | +$59K | -0.2% | $1.47T |
| Marble Harbor Investment Counsel, LLC | $54K | $1.33 | +$0 | +$4K | -0.0% | $923M |
Cost basis is a volume-weighted estimate from accumulation periods within our 13F history; holders who built their position before our window started will show a stale basis. % above the cost basis is the unrealized gain at the current price.
Trading behavior
Smart-money alpha (lifetime, %/qtr)BEARISH
Holders
-3.23%
avg per quarter
Holders (ex-self)
-3.22%
excl. this stock
Buyers (this Q)
-3.89%
22 buyers · $0.03B in
Sellers (this Q)
+0.36%
7 sellers · $0.00B out
alpha coverage: 100% of $ has a lifetime-alpha record
Holder behavior on this stocksource: stock
On big dips (−10%+)
+17.8%
how holders react when this stock falls
On quiet Qs
-2.7%
−10% to +10% baseline
On rallies (+10%+)
-15.5%
how they react when this stock rises
Holders' portfolio flow this Q
+10.4%
inflows — adds are organic
Sellers' portfolio flow this Q
-0.7%
Sellers' overall flow ~ flat.
▸ Compare to holder-profile behavior (across all their stocks)
Holder dip (any stock)
+3.2%
Holder mid (any stock)
-4.2%
Holder rally (any stock)
-16.4%
Biggest decreases this quarter
AdvisorShares Investments LLCexited−$570KBANK OF AMERICA CORP /DE/exited−$350KSUSQUEHANNA INTERNATIONAL GROUP, LLP−$180Kα-0.6Virtu Financial LLC−$162Kα-2.0MARSHALL WACE, LLPexited−$144KMORGAN STANLEY−$127Kα-0.3SIMPLEX TRADING, LLCexited−$31KWEALTH ENHANCEMENT ADVISORY SERVICES, LLCexited−$17KBoyer Financial Services, Inc.−$14Kα-3.0NewEdge Advisors, LLCexited−$5K
New buyers this quarter
Top-5 holders · 89.4%
MMCAP International Inc. SPC--
Tejara Capital Ltd--
Ikarian Capital, LLC--
CITADEL ADVISORS LLC--
BOOTHBAY FUND MANAGEMENT, LLC--
Top Holders Over Time
5-year share-count history (top 10 holders by peak, incl. exited) + price
hover the chart for per-quarter detailprice (right axis)
MMCAP International Inc. SPC15.4MTejara Capital Ltd5.1MMirae Asset Global Investments Co., Ltd.—Ikarian Capital, LLC2.7MAdvisorShares Investments LLC—AXS Investments LLC—CITADEL ADVISORS LLC820KBOOTHBAY FUND MANAGEMENT, LLC795KVerition Fund Management LLC—TWO SIGMA INVESTMENTS, LP534K
Analyst Coverage
Analyst Coverage
Analyst Ratings
2
Buy: 2Consensus: Buy
Corporate
Order Flow (FINRA, ~3w lag)
48.3%retail+7.0pp
8.1%dark-7.0pp
week of 2026-04-13
Off-exchange volume from FINRA. Retail = non-ATS (wholesaler PFOF + broker internalization). Dark = ATS (dark-pool crossing networks, institutional). Lit-exchange = remainder.